GoLYTELY (Physicians Total Care, Inc.)
Welcome to the PulseAid listing for the GoLYTELY drug offered from Physicians Total Care, Inc.. This Osmotic Activity [MoA],Osmotic Laxative [EPC],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Physicians Total Care, Inc. |
| NON-PROPRIETARY NAME: | PEG-3350 and electrolytes |
| SUBSTANCE NAME: | POLYETHYLENE GLYCOL 3350; SODIUM SULFATE ANHYDROUS; SODIUM BICARBONATE; SODIUM CHLORIDE; POTASSIUM CHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Osmotic Activity [MoA],Osmotic Laxative [EPC],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
| ROUTE: | NASOGASTRIC; ORAL |
| DOSAGE FORM: | POWDER, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2007-09-04 |
| END MARKETING DATE: | 0000-00-00 |
GoLYTELY HUMAN PRESCRIPTION DRUG Details:
| Item Description | GoLYTELY from Physicians Total Care, Inc. |
| LABELER NAME: | Physicians Total Care, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 236; 22.74; 6.74; 5.86; 2.97(g/2L; g/2L; g/2L; g/2L; g/2L) |
| START MARKETING DATE: | 2007-09-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 54868-0054_a0734292-7217-425b-98a3-acb7e8f2d429 |
| PRODUCT NDC: | 54868-0054 |
| APPLICATION NUMBER: | NDA019011 |
Other POLYETHYLENE GLYCOL 3350; SODIUM SULFATE ANHYDROUS; SODIUM BICARBONATE; SODIUM CHLORIDE; POTASSIUM CHLORIDE Pharmaceutical Manufacturers / Labelers:
